Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sibin,Zhang

第一单位： Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China.

作者： Sibin,Zhang ^[1] ; Xu,Xiao ^[1] ; Yu,Wang ^[2] ; Tianjun,Song ^[3] ; Chenlong,Li ^[1] ; Hongbo,Bao ^[1] ; Qing,Liu ^[1] ; Guiyin,Sun ^[1] ; Xiaoyang,Sun ^[1] ; Tianqi,Su ^[1] ; Tianjiao,Fu ^[1] ; Yujie,Wang ^[1] ; Peng,Liang ^[1]

作者单位： Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China. ^[1] Department of Esophageal Surgery, Harbin Medical University Cancer Hospital, Harbin, China. ^[2] Department of Medicine II, University Hospital LMU Munich, Munich, Germany. ^[3]

关键词 bioinformatics signature glioma immune enviroment immunetherapy prognosis

DOI 10.3389/fgene.2022.961153

PMID 36061198

发布时间 2022-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in genetics

2022年13卷

961153页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

检索历史清除